RYLTENDI

Swiss trademark · 824133 · Word mark · In force

Register entry

Registration number
824133
Application number
17306/2024
Status
In force
Type
Word mark
Filed
Dec 11, 2024
Registered
Dec 16, 2024
Published
Dec 16, 2024
Protected until
Dec 11, 2034
Priority
05.07.2024 EM
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Produkte für die Behandlung erwachsener Patienten mit der Parkinsonkrankheit durch Formulierungen von Levodopa/Dopa-Decarboxylase (DDC)-Hemmern.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 16, 2024

    Registered

    Published in Swissreg on 16.12.2024

Parties

Holder

Zambon Biotech SA

c/o Zambon Switzerland Ltd Via Industria 13, 6814 Cadempino

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.